Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)

V. Lavoue; C. Huchon; C. Akladios; P. Alfonsi; N. Bakrin; M. Ballester; S. Bendifallah; P. A. Bolze; F. Bonnet; C. Bourgin; N. Chabbert-Buffet; P. Collinet; B. Courbiere; T. De la motte rouge; M. Devouassoux-Shisheboran; C. Falandry; G. Ferron; L. Fournier; L. Gladieff; F. Golfier; S. Gouy; F. Guyon; E. Lambaudie; A. Leary; F. Lecuru; M. A. Lefrere-Belda; E. Leblanc; A. Lemoine; F. Narducci; L. Ouldamer; P. Pautier; F. Planchamp; N. Pouget; I. Ray-Coquard; C. Rousset-Jablonski; C. Senechal-Davin; C. Touboul; I. Thomassin-Naggara; C. Uzan; B. You; E. Daraï

doi:10.1016/j.jogoh.2019.03.018

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)

V. Lavoue, C. Huchon, C. Akladios, P. Alfonsi, N. Bakrin, M. Ballester, S. Bendifallah, P. A. Bolze, F. Bonnet, C. Bourgin, N. Chabbert-Buffet, P. Collinet, B. Courbiere, T. De la motte rouge, M. Devouassoux-Shisheboran, C. Falandry, G. Ferron, L. Fournier, L. Gladieff, F. GolfierS. Gouy, F. Guyon, E. Lambaudie, A. Leary, F. Lecuru, M. A. Lefrere-Belda, E. Leblanc, A. Lemoine, F. Narducci, L. Ouldamer, P. Pautier, F. Planchamp, N. Pouget, I. Ray-Coquard, C. Rousset-Jablonski, C. Senechal-Davin, C. Touboul, I. Thomassin-Naggara, C. Uzan, B. You, E. Daraï

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

22 Citations (Scopus)

Résumé

Adjuvant chemotherapy by carboplatin and paclitaxel is recommended for all high-grade ovarian and tubal cancers (FIGO stages I-IIA)(grade A). After primary surgery is complete, 6 cycles of intravenous chemotherapy (grade A)are recommended, or a discussion with the patient about intraperitoneal chemotherapy, according to her risk-benefit ratio. After complete interval surgery for FIGO stage III, hyperthermic intraperitoneal chemotherapy (HIPEC)can be proposed, in accordance with the modalities of the OV-HIPEC trial (grade B). In cases of postoperative tumor residue or in FIGO stage IV tumors, chemotherapy associated with bevacizumab is recommended (grade A).

langue originale	Anglais
Pages (de - à)	379-386
Nombre de pages	8
journal	Journal of Gynecology Obstetrics and Human Reproduction
Volume	48
Numéro de publication	6
Les DOIs	https://doi.org/10.1016/j.jogoh.2019.03.018
état	Publié - 1 juin 2019

Accès au document

10.1016/j.jogoh.2019.03.018

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Lavoue, V., Huchon, C., Akladios, C., Alfonsi, P., Bakrin, N., Ballester, M., Bendifallah, S., Bolze, P. A., Bonnet, F., Bourgin, C., Chabbert-Buffet, N., Collinet, P., Courbiere, B., De la motte rouge, T., Devouassoux-Shisheboran, M., Falandry, C., Ferron, G., Fournier, L., Gladieff, L., ... Daraï, E. (2019). Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up). Journal of Gynecology Obstetrics and Human Reproduction, 48(6), 379-386. https://doi.org/10.1016/j.jogoh.2019.03.018

Lavoue, V. ; Huchon, C. ; Akladios, C. et al. / Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up). Dans: Journal of Gynecology Obstetrics and Human Reproduction. 2019 ; Vol 48, Numéro 6. p. 379-386.

@article{e5f542986abc434184417ade92a5c002,

title = "Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)",

abstract = "Adjuvant chemotherapy by carboplatin and paclitaxel is recommended for all high-grade ovarian and tubal cancers (FIGO stages I-IIA)(grade A). After primary surgery is complete, 6 cycles of intravenous chemotherapy (grade A)are recommended, or a discussion with the patient about intraperitoneal chemotherapy, according to her risk-benefit ratio. After complete interval surgery for FIGO stage III, hyperthermic intraperitoneal chemotherapy (HIPEC)can be proposed, in accordance with the modalities of the OV-HIPEC trial (grade B). In cases of postoperative tumor residue or in FIGO stage IV tumors, chemotherapy associated with bevacizumab is recommended (grade A).",

keywords = "Chemotherapy, Guidelines, Ovarian cancer, Primary peritoneal cancer, Surgery, Tubal cancer",

author = "V. Lavoue and C. Huchon and C. Akladios and P. Alfonsi and N. Bakrin and M. Ballester and S. Bendifallah and Bolze, {P. A.} and F. Bonnet and C. Bourgin and N. Chabbert-Buffet and P. Collinet and B. Courbiere and {De la motte rouge}, T. and M. Devouassoux-Shisheboran and C. Falandry and G. Ferron and L. Fournier and L. Gladieff and F. Golfier and S. Gouy and F. Guyon and E. Lambaudie and A. Leary and F. Lecuru and Lefrere-Belda, {M. A.} and E. Leblanc and A. Lemoine and F. Narducci and L. Ouldamer and P. Pautier and F. Planchamp and N. Pouget and I. Ray-Coquard and C. Rousset-Jablonski and C. Senechal-Davin and C. Touboul and I. Thomassin-Naggara and C. Uzan and B. You and E. Dara{\"i}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Masson SAS",

year = "2019",

month = jun,

day = "1",

doi = "10.1016/j.jogoh.2019.03.018",

language = "English",

volume = "48",

pages = "379--386",

journal = "Journal of Gynecology Obstetrics and Human Reproduction",

issn = "2468-7847",

number = "6",

}

Lavoue, V, Huchon, C, Akladios, C, Alfonsi, P, Bakrin, N, Ballester, M, Bendifallah, S, Bolze, PA, Bonnet, F, Bourgin, C, Chabbert-Buffet, N, Collinet, P, Courbiere, B, De la motte rouge, T, Devouassoux-Shisheboran, M, Falandry, C, Ferron, G, Fournier, L, Gladieff, L, Golfier, F, Gouy, S, Guyon, F, Lambaudie, E, Leary, A, Lecuru, F, Lefrere-Belda, MA, Leblanc, E, Lemoine, A, Narducci, F, Ouldamer, L, Pautier, P, Planchamp, F, Pouget, N, Ray-Coquard, I, Rousset-Jablonski, C, Senechal-Davin, C, Touboul, C, Thomassin-Naggara, I, Uzan, C, You, B & Daraï, E 2019, 'Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)', Journal of Gynecology Obstetrics and Human Reproduction, VOL. 48, Numéro 6, p. 379-386. https://doi.org/10.1016/j.jogoh.2019.03.018

Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up). / Lavoue, V.; Huchon, C.; Akladios, C. et al.
Dans: Journal of Gynecology Obstetrics and Human Reproduction, Vol 48, Numéro 6, 01.06.2019, p. 379-386.

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

TY - JOUR

T1 - Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up)

AU - Lavoue, V.

AU - Huchon, C.

AU - Akladios, C.

AU - Alfonsi, P.

AU - Bakrin, N.

AU - Ballester, M.

AU - Bendifallah, S.

AU - Bolze, P. A.

AU - Bonnet, F.

AU - Bourgin, C.

AU - Chabbert-Buffet, N.

AU - Collinet, P.

AU - Courbiere, B.

AU - De la motte rouge, T.

AU - Devouassoux-Shisheboran, M.

AU - Falandry, C.

AU - Ferron, G.

AU - Fournier, L.

AU - Gladieff, L.

AU - Golfier, F.

AU - Gouy, S.

AU - Guyon, F.

AU - Lambaudie, E.

AU - Leary, A.

AU - Lecuru, F.

AU - Lefrere-Belda, M. A.

AU - Leblanc, E.

AU - Lemoine, A.

AU - Narducci, F.

AU - Ouldamer, L.

AU - Pautier, P.

AU - Planchamp, F.

AU - Pouget, N.

AU - Ray-Coquard, I.

AU - Rousset-Jablonski, C.

AU - Senechal-Davin, C.

AU - Touboul, C.

AU - Thomassin-Naggara, I.

AU - Uzan, C.

AU - You, B.

AU - Daraï, E.

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Adjuvant chemotherapy by carboplatin and paclitaxel is recommended for all high-grade ovarian and tubal cancers (FIGO stages I-IIA)(grade A). After primary surgery is complete, 6 cycles of intravenous chemotherapy (grade A)are recommended, or a discussion with the patient about intraperitoneal chemotherapy, according to her risk-benefit ratio. After complete interval surgery for FIGO stage III, hyperthermic intraperitoneal chemotherapy (HIPEC)can be proposed, in accordance with the modalities of the OV-HIPEC trial (grade B). In cases of postoperative tumor residue or in FIGO stage IV tumors, chemotherapy associated with bevacizumab is recommended (grade A).

AB - Adjuvant chemotherapy by carboplatin and paclitaxel is recommended for all high-grade ovarian and tubal cancers (FIGO stages I-IIA)(grade A). After primary surgery is complete, 6 cycles of intravenous chemotherapy (grade A)are recommended, or a discussion with the patient about intraperitoneal chemotherapy, according to her risk-benefit ratio. After complete interval surgery for FIGO stage III, hyperthermic intraperitoneal chemotherapy (HIPEC)can be proposed, in accordance with the modalities of the OV-HIPEC trial (grade B). In cases of postoperative tumor residue or in FIGO stage IV tumors, chemotherapy associated with bevacizumab is recommended (grade A).

KW - Chemotherapy

KW - Guidelines

KW - Ovarian cancer

KW - Primary peritoneal cancer

KW - Surgery

KW - Tubal cancer

UR - http://www.scopus.com/inward/record.url?scp=85063802595&partnerID=8YFLogxK

U2 - 10.1016/j.jogoh.2019.03.018

DO - 10.1016/j.jogoh.2019.03.018

M3 - Article

C2 - 30936025

AN - SCOPUS:85063802595

SN - 2468-7847

VL - 48

SP - 379

EP - 386

JO - Journal of Gynecology Obstetrics and Human Reproduction

JF - Journal of Gynecology Obstetrics and Human Reproduction

IS - 6

ER -

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M et al. Management of epithelial cancer of the ovary, fallopian tube, primary peritoneum. Long text of the joint French clinical practice guidelines issued by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY, endorsed by INCa. (Part 2: systemic, intraperitoneal treatment, elderly patients, fertility preservation, follow-up). Journal of Gynecology Obstetrics and Human Reproduction. 2019 juin 1;48(6):379-386. doi: 10.1016/j.jogoh.2019.03.018